Why does pancreatic cancer develop, what new therapies might be effective against metastasis formation, and what is to be considered in palliative care? Members of the German National Academy of Sciences Leopoldina will address these questions at the virtual symposium of Class III Medicine.
Online-Symposium Class III - Medicine
"New advances in medicine"
Tuesday, 6 July 2021, 5:30 p.m. - 7:00 p.m. (Berlin/Germany)
Online via Zoom
Class III Academy members share insights into their current medical research at this online symposium.
- Professor Aurel Perren (Director of the Institute of Pathology, University of Bern/Switzerland): "What is the origin of pancreatic endocrine tumors? Of molecular markers in precision medicine and cells of origin". Perren talks about the development of rare pancreatic tumors and molecular markers that can be used to identify the cells of origin of this type of cancer. These findings may help to further improve personalized cancer therapies and precision medicine in the future.
- Professor Thomas Brabletz (Chair of Experimental Medicine, Friedrich Alexander University Erlangen-Nuremberg/Germany): "Cancer metastasis - fatal process, fascinating mechanisms, therapeutic strategies". Brabletz investigates which processes and mechanisms lead to metastases formation. In his lecture, he presents the research results and explains how new therapeutic approaches can be developed on that basis.
- Professor Lukas Radbruch (Director of the Clinic for Palliative Medicine, University Hospital Bonn/Germany): "Resilience and Sense of Coherence in palliative care". Radbruch addresses ethical questions at the end of life. He talks about the importance of resilience and sense of coherence in palliative and end-of-life care.
The program can be found at: https://www.leopoldina.org/veranstaltungen/veranstaltung/event/2890/
Follow the Leopoldina on Twitter: http://www.twitter.com/leopoldina
If you, as a journalist, would like to attend this event, please register by e-mail at: email@example.com
About the German National Academy of Sciences Leopoldina
As the German National Academy of Sciences, the Leopoldina provides independent science-based policy advice on matters relevant to society. To this end, the Academy develops interdisciplinary statements based on scientific findings. In these publications, options for action are outlined; making decisions, however, is the responsibility of democratically legitimized politicians. The experts who prepare the statements work in a voluntary and unbiased manner. The Leopoldina represents the German scientific community in the international academy dialogue. This includes advising the annual summits of Heads of State and Government of the G7 and G20 countries. With 1,600 members from more than 30 countries, the Leopoldina combines expertise from almost all research areas. Founded in 1652, it was appointed the National Academy of Sciences of Germany in 2008. The Leopoldina is committed to the common good.
Dr. Kathrin Happe
Deputy Head of Department Science - Policy - Society
Head of the Department Press and Public Relations
Tel.: +49 (0)345 472 39-800